Migdal Insurance & Financial Holdings’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-97
Closed -$26K 673
2020
Q3
$26K Buy
+97
New +$26.1K ﹤0.01% 601
2020
Q2
Sell
-191
Closed -$43K 714
2020
Q1
$43K Sell
191
-212
-53% -$57.8K ﹤0.01% 506
2019
Q4
$122K Sell
403
-43
-10% -$11.8K ﹤0.01% 484
2019
Q3
$107K Buy
+446
New +$122K ﹤0.01% 539
2018
Q4
Sell
-1,854
Closed -$508K 730
2018
Q3
$508K Buy
1,854
+1,110
+149% +$288K 0.01% 373
2018
Q2
$177K Buy
744
+721
+3,135% +$167K ﹤0.01% 452
2018
Q1
$5K Buy
+23
New +$5.4K ﹤0.01% 569

Other funds holding ELV

Migdal Insurance & Financial Holdings's ELV Position: Q4 2020 in Review

Migdal Insurance & Financial Holdings sold out of Elevance Health (ELV) in Q4 2020, closing a stake of 97 shares — an estimated $26K sold.

Migdal Insurance & Financial Holdings first reported a position in ELV in Q1 2018 and held it in 7 quarters. The position peaked at $508K in Q3 2018. 1,171 funds tracked by Wall St. Rank hold ELV as of Q4 2020.

  • Migdal Insurance & Financial Holdings reported no remaining Elevance Health position as of Q4 2020 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 97 Elevance Health shares in Q4 2020, an estimated $26K.
  • Migdal Insurance & Financial Holdings first reported a position in Elevance Health in Q1 2018 and held it in 7 quarters.
  • Migdal Insurance & Financial Holdings's Elevance Health position peaked at $508K in Q3 2018.
  • 1,171 funds tracked by Wall St. Rank held Elevance Health as of Q4 2020.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q4 2020, filed 8 Feb 2021.